Medical Cannabis: An Evidence-Based Approach for Pharmacy Teams [Technician]
Medical Cannabis: An Evidence-Based Approach for Pharmacy Teams [Technician]
This course provides pharmacy technicians with a review of the endocannabinoid system, available medical cannabis products, patient safety, drug interactions, and important dispensing information.
Upon successful completion of this knowledge-based CPE course, pharmacy technicians should be able to:
1. Review the pharmacology of cannabis
2. Describe effectiveness and adverse effects of medical cannabis based on clinical literature
3. Identify potential patient safety issues that may occur with the use of medical cannabis
Laura Borgelt, PharmD, FCCP, BCPS
Associate Dean for Administration and Operations
Professor, Departments of Clinical Pharmacy and Family Medicine
Skaggs School of Pharmacy and Pharmaceutical Sciences
University of Colorado
Kelsey Schwander, PharmD
Clinical Assistant Professor
Skaggs School of Pharmacy and Pharmaceutical Sciences
University of Colorado
Dr. Borgelt and Dr. Schwander have no relevant financial relationships with ineligible companies to disclose.
Course fee includes course, course materials, and CPE credit submission to CPE Monitor.
Course is non-refundable.
Release Date: April 15, 2023
Planned Expiration Date: April 15, 2026
RV1-1.24
CEImpact is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Obtain CPE credit by completing the course, followed by the exam and evaluation (if applicable). Once successfully completed, your course will appear in your Completed Courses tab. Access your CPE statement of credit at www.MyCPEMonitor.net.
¹CEImpact provides you with two (2) opportunities to complete the exam. The learner will not receive CPE credit after two failed attempts.
Additional information
| Duration | 1h 30m |
|---|---|
| Topic Designator | Disease State/Drug Therapy |
| ACPE | Yes |
| ACPE Topic | 01 Drug Therapy |
| Role | Technician |
| Media-Type | On-Demand |
| Release Date | 4/15/23 |
| CEUs | 0.15 |
| Rating | 4 |
| ACPE Number | 0107-0000-23-129-H01-T |
